CLPT
ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (CLPT) has 17 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 6, 2026.
Insiders have net sold $1.8M over the trailing 6 months.
- Industry:Medical - Devices
- CEO:Joseph Michael Burnett
- Employees:115
- HQ:Solana Beach, CA, US
- IPO:2012-05-22
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.8M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$434.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CEO and President | Sale | 20,000 | $388K | Jul 1 | SEC ↗ | |
BURNETT JOSEPHFirst filing | CEO and President | Sale | 61,843 | $1.1M | Jun 22 | SEC ↗ |
Richards Timothy T.First filing | Director | Sale | 5,415 | $66K | Jun 2 | SEC ↗ |
| Director | Sale | 16,000 | $185K | May 26 | SEC ↗ | |
FALLON LYNNETTE CFirst filing | Director | Sale | 5,091 | $57K | May 21 | SEC ↗ |
Related companies
ClearPoint Neuro, Inc. is in the Healthcare sector.